Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial
Peey Sei Kok, Patrick M. Forde, Brett Hughes, Zhuoxin Sun, Chris Brown, Suresh Ramalingam, Alistair Cook, Willem Joost Lesterhuis, Sonia Yip, Ken O'Byrne, Nick Pavlakis, Julie Brahmer, Valsamo Anagnostou, Kate Ford, Karen Fitzpatrick, Alison Bricker, Michelle M. Cummins, Martin Stockler, Anna K. Nowak
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial'. Together they form a unique fingerprint.